联合MR指纹成像与扩散检查用于前列腺癌的开发研究
本研究纳入140例疑似前列腺癌患者,采用基于快速稳态进动MR指纹成像的T1、T2定量图联合标准ADC图进行多参数表征,分析109个病灶。结果显示癌灶T1、T2、ADC均显著低于正常表现外周带,三者联合鉴别两者AUC达0.99;ADC联合T2鉴别高中级别与低级别肿瘤AUC为0.83。
要点
- 癌灶T1、T2、ADC均显著低于正常表现外周带,三者联合鉴别AUC达0.99。
- ADC联合T2鉴别高中级别与低级别肿瘤的AUC最高,为0.83。
- 前列腺炎T1、T2、ADC亦显著低于正常表现外周带。
核心结论
- 本研究开发了一种基于快速MR指纹成像与扩散的检查,用于前列腺组织的定量表征。
研究设计与样本
- 经机构审查委员会批准、符合HIPAA的回顾性研究,分析前瞻性收集的数据,纳入140例疑似前列腺癌患者;采用基于快速稳态进动MR指纹成像的T1、T2定量图联合ADC图;由两名独立阅片者在外周带病灶及临床图像识别的正常表现外周带勾画感兴趣区;病理对照基于系统经直肠穿刺活检或认知靶向活检结果。
关键影像表现/征象
- 癌灶T1、T2、ADC均值分别为1628毫秒±344、73毫秒±27、0.773×10⁻³ mm²/秒±0.331,均显著低于正常表现外周带的2247毫秒±450、169毫秒±61、1.711×10⁻³ mm²/秒±0.269(每项P<.0001)。
- 前列腺炎灶T1、T2、ADC均值分别为1707毫秒±377、79毫秒±37、0.911×10⁻³ mm²/秒±0.239,均显著低于正常表现外周带(每项P<.0005)。
诊断标准与关键数值
- 癌灶 vs 正常表现外周带:T1、T2、ADC三者联合鉴别AUC=0.99。
- 高中级别肿瘤 vs 低级别肿瘤:ADC联合T2鉴别AUC最高,为0.83。
- T1、T2测量阅片者间一致性极好,组内相关系数均大于0.75。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To develop and evaluate an examination consisting of magnetic resonance (MR) fingerprinting-based T1, T2, and standard apparent diffusion coefficient (ADC) mapping for multiparametric characterization of prostate disease. Materials and Methods This institutional review board-approved, HIPAA-compliant retrospective study of prospectively collected data included 140 patients suspected of having prostate cancer. T1 and T2 mapping was performed with fast imaging with steady-state precession-based MR fingerprinting with ADC mapping. Regions of interest were drawn by two independent readers in peripheral zone lesions and normal-appearing peripheral zone (NPZ) tissue identified on clinical images. T1, T2, and ADC were recorded for each region. Histopathologic correlation was based on systematic transrectal biopsy or cognitively targeted biopsy results, if available. Generalized estimating equations logistic regression was used to assess T1, T2, and ADC in the differentiation of (a) cancer versus NPZ, (b) cancer versus prostatitis, (c) prostatitis versus NPZ, and (d) high- or intermediate-grade tumors versus low-grade tumors. Analysis was performed for all lesions and repeated in a targeted biopsy subset. Discriminating ability was evaluated by using the area under the receiver operating characteristic curve (AUC). Results In this study, 109 lesions were analyzed, including 39 with cognitively targeted sampling. T1, T2, and ADC from cancer (mean, 1628 msec ± 344, 73 msec ± 27, and 0.773 × 10-3 mm2/sec ± 0.331, respectively) were significantly lower than those from NPZ (mean, 2247 msec ± 450, 169 msec ± 61, and 1.711 × 10-3 mm2/sec ± 0.269) (P < .0001 for each) and together produced the best separation between these groups (AUC = 0.99). ADC and T2 together produced the highest AUC of 0.83 for separating high- or intermediate-grade tumors from low-grade cancers. T1, T2, and ADC in prostatitis (mean, 1707 msec ± 377, 79 msec ± 37, and 0.911 × 10-3 mm2/sec ± 0.239) were significantly lower than those in NPZ (P < .0005 for each). Interreader agreement was excellent, with an intraclass correlation coefficient greater than 0.75 for both T1 and T2 measurements. Conclusion This study describes the development of a rapid MR fingerprinting- and diffusion-based examination for quantitative characterization of prostatic tissue. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Yu AC, Badve C, Ponsky LE, et al. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer. Radiology. 2017. PMID: 28187264. doi:10.1148/radiol.2017161599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。